72067423RFA00001: Accelerate TB Elimination and Program Resilience Activity 2
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of South Africa USAID-Pretoria notices from 2022.
South Africa USAID-Pretoria offered grants of up to $47.0 million to the applicants described in the notice. It expected to make one award. Applications closed on January 19, 2023.
From the official notice on Grants.gov, last changed November 18, 2022. Checked November 7, 2026.
- Award ceiling$47.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | November 18, 2022 |
|---|---|
| Deadline | January 19, 2023 |
| Archived by Grants.gov | February 18, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility is restricted to local entities. For purposes of consistency and reporting, the definition of “local entity” means an individual, a corporation, a nonprofit organization, or another body of persons that: (1) Is legally organized under the laws of South Africa; (2) Has as its principal place of business or operations in South Africa; (3) Is majority owned by individuals who are citizens or lawful permanent residents of South Africa; and (4) Is managed by a governing body the majority of who are citizens or lawful permanent residents of the country receiving assistance. For purposes of this definition, ‘majority owned’ and ‘managed by’ include, without limitation, beneficiary interests and the power, either directly or indirectly, whether exercised or exercisable, to control the election, appointment, or tenure of the organization's managers or a majority of the organization's governing body by any means. USAID welcomes applications from eligible organizations which have not previously received financial assistance from USAID. International or U.S. organizations are not eligible to submit an application for an award as a prime applicant under this request for applications. Applicants must have established financial management, monitoring and evaluation processes, internal control systems, and policies and procedures that comply with established U.S. Government standards, laws, and regulations. The successful applicant(s) may be subject to a responsibility determination assessment (Pre-award Survey) by the Agreement Officer (AO).The Recipient must be a responsible entity. The AO may determine a pre-award survey is required to conduct an examination that will determine whether the prospective recipient has the necessary organization, experience, accounting and operational controls, and technical skills – or ability to obtain them – in order to achieve the objectives of the program and comply with the terms and conditions of the award.
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $47.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The purpose of ACCELERATE - Accelerate TB Elimination and Program Resilience Activity is to support South Africa’s efforts to achieve TB elimination through early detection, appropriate treatment and care, and prevention among vulnerable populations, particularly those infected with TB, drug resistant TB (DR-TB), or TB/HIV co-infection. ACCELERATE is the flagship USAID/SA TB project which comprises two separate activities - ACCELERATE 1 targets technical support and interventions at the national, provincial level and in high TB burden districts. ACCELERATE 2 hereinafter referred to as the Activity targets technical support and interventions at the provincial, district, facility and community level in lower TB burden districts and will advance overall progress towards TB elimination by fast tracking elimination in lower TB burden districts.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72067423RFA00001 still open?
No. It closed on January 19, 2023.
Who can apply for Accelerate TB Elimination and Program Resilience Activity 2?
South Africa USAID-Pretoria accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Accelerate TB Elimination and Program Resilience Activity 2?
Closed January 19, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $47.0 million each.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)